Business Description
DermTech Inc
NAICS : 621512
SIC : 8099
ISIN : VGG2379F1080
Description
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.56 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.63 | |||||
| Debt-to-EBITDA | -0.47 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -4.78 | |||||
| Beneish M-Score | -5.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -70 | |||||
| 3-Year FCF Growth Rate | -166.7 | |||||
| 3-Year Book Growth Rate | 25.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.3 | |||||
| 9-Day RSI | 26.69 | |||||
| 14-Day RSI | 29.82 | |||||
| 6-1 Month Momentum % | -30.34 | |||||
| 12-1 Month Momentum % | -46.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.85 | |||||
| Quick Ratio | 5.77 | |||||
| Cash Ratio | 5.38 | |||||
| Days Inventory | 36.93 | |||||
| Days Sales Outstanding | 123.84 | |||||
| Days Payable | 50.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -124.7 | |||||
| Shareholder Yield % | -57.19 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -5.8 | |||||
| Operating Margin % | -872.2 | |||||
| Net Margin % | -853.02 | |||||
| ROE % | -90.46 | |||||
| ROA % | -63.2 | |||||
| ROIC % | -194.9 | |||||
| ROC (Joel Greenblatt) % | -253.24 | |||||
| ROCE % | -70.57 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.58 | |||||
| PB Ratio | 0.62 | |||||
| Price-to-Tangible-Book | 0.62 | |||||
| EV-to-EBIT | -0.2 | |||||
| EV-to-EBITDA | -0.21 | |||||
| EV-to-Revenue | 1.72 | |||||
| EV-to-Forward-Revenue | 0.14 | |||||
| EV-to-FCF | -0.26 | |||||
| Price-to-Net-Current-Asset-Value | 2.23 | |||||
| Price-to-Net-Cash | 3.24 | |||||
| Earnings Yield (Greenblatt) % | -500 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DMTK
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DermTech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 14.024 | ||
| EPS (TTM) ($) | -3.9 | ||
| Beta | 3.47 | ||
| Volatility % | 227.87 | ||
| 14-Day RSI | 29.82 | ||
| 14-Day ATR ($) | 0.154618 | ||
| 20-Day SMA ($) | 1.997 | ||
| 12-1 Month Momentum % | -46.93 | ||
| 52-Week Range ($) | 1.55 - 6.44 | ||
| Shares Outstanding (Mil) | 33.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DermTech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DermTech Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
DermTech Inc Frequently Asked Questions
What is DermTech Inc(DMTK)'s stock price today?
The current price of DMTK is $1.64. The 52 week high of DMTK is $6.44 and 52 week low is $1.55.
When is next earnings date of DermTech Inc(DMTK)?
The next earnings date of DermTech Inc(DMTK) is 2023-11-03 Est..
Does DermTech Inc(DMTK) pay dividends? If so, how much?
DermTech Inc(DMTK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers